Northwest Biotherapeutics (OTCQB; NWBO) Announces Presentation At Inaugural Glioblastoma Drug Development Summit

Author's Avatar
Dec 11, 2019
Article's Main Image

NW Bio CTO To Highlight History Of DCVax®-L and Phase III Clinical Trial

PR Newswire